Tips for Assessing Patients' Risk of Opioid Overdose

Article
Conference|PainWeek

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system pharmacists can assess patients' risk for opioid overdose.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system pharmacists can assess patients' risk for opioid overdose.

Related Videos
View in microscopic of pathology cross section tissue ductal cell carcinoma or adenocarcinoma diagnosis by pathologist in laboratory | Image Credit: arcyto - stock.adobe.com
A female doctor sits at her desk and talks to a female patient while looking at her mammogram | Image Credit: lordn - stock.adobe.com
Doctor holding a digital tablet with x-ray of brain and skull skeleton. Headache, meningitis and migraine concept - Image credit: Steph photographies | stock.adobe.com
Woman Physician Talking With Her Patient | Image Credit: LStockStudio - stock.adobe.com
A health visitor explaining a senior woman how to take pills - Image credit: Halfpoint | stock.adobe.com
Diabetes patient turn knob on end of insulin pen and dial up correct insulin dose for injection. Scale window on pen syringe showing number of units dose. Medical equipment is easy to self injection - Image credit: Orawan | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Related Content
Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

December 7th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 2

Pharmacy Focus: Conversations On Reproductive Health - Episode 2

November 29th 2023
Podcast
Abemaciclib, Nonsteroidal Aromatase Inhibitor Extends Overall Survival for Patients With HR+, HER2- Advanced Breast Cancer

Abemaciclib, Nonsteroidal Aromatase Inhibitor Extends Overall Survival for Patients With HR+, HER2- Advanced Breast Cancer

December 7th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 1

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023
Podcast
Study: Patients With PD-L1-Positive, High-Risk, ER+/HER2- Breast Cancer Can Achieve Substantial Complete Response Rates With Addition of Nivolumab

Study: Patients With PD-L1-Positive, High-Risk, ER+/HER2- Breast Cancer Can Achieve Substantial Complete Response Rates With Addition of Nivolumab

December 6th 2023
Article
Close up view of doctor touching patient hand, showing empty and kindness - Image credit: Bongkarn | stock.adobe.com

Expert Discusses A Health System Specialty Pharmacy Initiative: Abemaciclib Linkage to Care

December 6th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.